Author:
Kudo Yoshikuni,Terao Hideo,Takeuchi Hiroaki,Zeze Kenji,Kawasaki Hisanori,Kodama Masaaki,Murakami Kazunari,Fujioka Toshio
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,General Medicine
Reference24 articles.
1. Taura N, Hamasaki K, Nakao K, Ichikawa T, Nishimura D, Goto T, et al. Aging of patients with hepatitis C virus-associated hepatocellular carcinoma: long-term trends in Japan. Oncol Rep. 2006;16:837–43.
2. Okita K. Clinical aspects of hepatocellular carcinoma in Japan. Intern Med. 2006;45:229–33.
3. Ikeda K, Saitoh S, Tsubota A, Arase Y, Chayama K, Kumada H, et al. Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma. Cancer. 1993;71:19–25.
4. Arima M, Terao H, Kashima K, Arita T, Nasu M, Nishizono A. Regression of liver fibrosis in cases of chronic liver disease type C: quantitative evaluation by using computed image analysis. Intern Med. 2004;43:902–10.
5. Nishiguchi S, Kuroki T, Nakatani S, Morimoto H, Takeda T, Nakajima S, et al. Randomized trial of effects of interferon-α on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet. 1995;346:1051–5.